Brief: Microba Life Sciences Says A$4.00M In Q3 FY24 Unaudited Revenue
23/04/2024 02:53
April 23 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* A$4.00M IN Q3 FY24 UNAUDITED REVENUE, UP 297% YOY
Further company coverage: MAP.AX
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million